Electrophysiologic approach to atrial fibrillation.
作者信息
Cotoi S, Georgescu C
出版信息
Med Interne. 1979 Oct-Dec;17(4):371-8.
PMID:515662
Abstract
摘要
相似文献
1
Electrophysiologic approach to atrial fibrillation.心房颤动的电生理研究方法
Med Interne. 1979 Oct-Dec;17(4):371-8.
2
Class 1 antiarrhythmic agents for therapy of atrial fibrillation.用于治疗心房颤动的Ⅰ类抗心律失常药物。
Herz. 1993 Feb;18(1):9-19.
3
Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?心房重构是预防房颤复发的可行靶点吗？
J Cardiovasc Electrophysiol. 2004 Aug;15(8):885-6. doi: 10.1046/j.1540-8167.2004.04325.x.
4
Novel anti-arrhythmic agents for the treatment of atrial fibrillation.用于治疗心房颤动的新型抗心律失常药物。
Curr Opin Pharmacol. 2007 Apr;7(2):214-8. doi: 10.1016/j.coph.2006.10.007. Epub 2007 Feb 15.
5
[Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].[心房颤动患者窦性心律的恢复与维持。新的药理学方法]
Dtsch Med Wochenschr. 2008 Dec;133(49):2572-8. doi: 10.1055/s-0028-1105856. Epub 2008 Nov 27.
6
Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon?心房颤动中增强的晚期钠电流：新的药物靶点还是仅仅是一种附带现象？
J Am Coll Cardiol. 2010 May 25;55(21):2343-5. doi: 10.1016/j.jacc.2010.01.046.
7
Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
J Cardiovasc Electrophysiol. 2005 Jun;16(6):677; author reply 677. doi: 10.1046/j.1540-8167.2005.50022.x.
8
[Efficacy of cibenzoline in a case of atrial fibrillation due to cardiac thyrotoxicosis].[西苯唑啉治疗一例心脏性甲状腺毒症所致心房颤动的疗效]
Ann Cardiol Angeiol (Paris). 1999 Feb;48(2):113-7; discussion 118.
9
The monophasic action potential: a simple in vivo model to evaluate the effects of antiarrhythmic drugs at atrial level.单相动作电位：一种评估抗心律失常药物对心房水平影响的简单体内模型。
Rom J Intern Med. 1998 Jan-Jun;36(1-2):37-46.
10
[Anti-arrhythmia agents].[抗心律失常药物]
Med Klin. 1974 May 3;69(18):778-86.
Zotero 插件